BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7585029)

  • 1. Radical directions in Parkinson's disease.
    Fisher LJ; Gage FH
    Nat Med; 1995 Mar; 1(3):201-3. PubMed ID: 7585029
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease.
    Nakao N; Frodl EM; Widner H; Carlson E; Eggerding FA; Epstein CJ; Brundin P
    Nat Med; 1995 Mar; 1(3):226-31. PubMed ID: 7585038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of neurotrophin-5 on the growth and survival of nigral grafts in a rat model of Parkinson's disease.
    Haque NS; Hlavin ML; Fawcett J; Dunnett SB
    Gene Ther; 1994; 1 Suppl 1():S60. PubMed ID: 8542406
    [No Abstract]   [Full Text] [Related]  

  • 4. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results.
    Kirik D; Björklund A
    Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
    Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
    J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-species neural grafting in a rat model of Parkinson's disease.
    Björklund A; Stenevi U; Dunnett SB; Gage FH
    Nature; 1982 Aug; 298(5875):652-4. PubMed ID: 7099260
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.
    Mendez I; Sanchez-Pernaute R; Cooper O; Viñuela A; Ferrari D; Björklund L; Dagher A; Isacson O
    Brain; 2005 Jul; 128(Pt 7):1498-510. PubMed ID: 15872020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Parkinson's disease. Symptomatic cell therapies: cells as biological minipumps.
    Zurn AD; Tseng J; Aebischer P
    Eur Neurol; 1996; 36(6):405-8. PubMed ID: 8954314
    [No Abstract]   [Full Text] [Related]  

  • 9. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
    Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
    Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplants in Parkinson's disease.
    Lindvall O
    Eur Neurol; 1991; 31 Suppl 1():17-27. PubMed ID: 1855521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic cell cloned transgenic bovine neurons for transplantation in parkinsonian rats.
    Zawada WM; Cibelli JB; Choi PK; Clarkson ED; Golueke PJ; Witta SE; Bell KP; Kane J; Ponce de Leon FA; Jerry DJ; Robl JM; Freed CR; Stice SL
    Nat Med; 1998 May; 4(5):569-74. PubMed ID: 9585230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine neurone grafting to the weaver mouse neostriatum.
    Triarhou LC; Low WC; Ghetti B
    Prog Brain Res; 1990; 82():187-95. PubMed ID: 2290935
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.
    Thompson L; Barraud P; Andersson E; Kirik D; Björklund A
    J Neurosci; 2005 Jul; 25(27):6467-77. PubMed ID: 16000637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clues to the mechanism underlying dopamine cell death in Parkinson's disease.
    Jenner P
    J Neurol Neurosurg Psychiatry; 1989 Jun; Suppl(Suppl):22-8. PubMed ID: 2666576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural transplantation (auto-adrenal, fetal nigral and fetal adrenal) in Parkinson's disease: the Mexican experience.
    Madrazo I; Franco-Bourland R; Ostrosky-Solis F; Aguilera M; Cuevas C; Alvarez F; Magallon E; Zamorano C; Morelos A
    Prog Brain Res; 1990; 82():593-602. PubMed ID: 1981281
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cell therapy for Parkinson's disease].
    Morizane A; Takahashi J
    Nihon Yakurigaku Zasshi; 2016 May; 147(5):264-8. PubMed ID: 27181719
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transplantation of fetal dopaminergic cells simultaneously to the corpus striatum and pars reticularis of the substantia nigra in hemi-parkinsonian rats].
    Blanco L; Pavón N; Alvaŕez P; Díaz C; Castellano O; Castillo L; de la Cuétara K; Macías R
    Rev Neurol; 1998 Mar; 26(151):361-5. PubMed ID: 9585942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural transplant.
    Madrazo I
    J Neurosurg; 2002 Aug; 97(2):497-8; author reply 498. PubMed ID: 12186488
    [No Abstract]   [Full Text] [Related]  

  • 19. Researchers broaden the attack on Parkinson's disease.
    Barinapa M
    Science; 1995 Jan; 267(5197):455-6. PubMed ID: 7824944
    [No Abstract]   [Full Text] [Related]  

  • 20. Neural transplantation: a hope for patients with Parkinson's disease.
    Lindvall O
    Neuroreport; 1997 Sep; 8(14):iii-x. PubMed ID: 9331903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.